Status:
COMPLETED
Low-Dose Radiation Therapy in Treating Patients With Follicular or Marginal Zone Non-Hodgkin's Lymphoma
Lead Sponsor:
University College, London
Conditions:
Lymphoma
Eligibility:
All Genders
18+ years
Phase:
PHASE3
Brief Summary
RATIONALE: Radiation therapy uses high-energy x-rays to kill cancer cells. It is not yet known which regimen of low-dose radiation therapy is more effective in treating follicular non-Hodgkin's lympho...
Detailed Description
OBJECTIVES: Primary * Compare the local progression-free interval in patients with follicular non-Hodgkin's lymphoma (NHL) treated with 2 different regimens of low-dose radiotherapy. Secondary * C...
Eligibility Criteria
Inclusion
- DISEASE CHARACTERISTICS:
- Histologically confirmed follicular or mmarginal zone non-Hodgkin's lymphoma (NHL)
- Any stage
- Radiotherapy is indicated for curative treatment of stage IA or IIA disease OR palliation due to tumor bulk or anatomical position
- PATIENT CHARACTERISTICS:
- Life expectancy \> 3 months
- PRIOR CONCURRENT THERAPY:
- More than 4 weeks since prior chemotherapy
Exclusion
Key Trial Info
Start Date :
October 1 2005
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
January 1 2017
Estimated Enrollment :
614 Patients enrolled
Trial Details
Trial ID
NCT00310167
Start Date
October 1 2005
End Date
January 1 2017
Last Update
November 17 2017
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Cancer Research UK and University College London Cancer Trials Centre
London, England, United Kingdom, W1T 4TJ